Molecular Genetics and Clinicla Advances in the Study of Esophageal and Gastric Cancers
This workshop offers in-depth seminars on molecular, genetics and clinical studies on esophageal and gastric cancers.
China has one of the highest incidences of esophageal and gastric cancers in the world. In HK, esophageal cancer is the 7th and stomach the 4th most common cause of cancer deaths. Despite treatments, both cancers have a poor prognosis, except in those with early cancers, which are usually not diagnosed because patients with early disease are asymptomatic. In order to improve outcome, one must understand the mechanisms of carcinogenesis and the molecular genetic basis of these cancers, explore ways to prevent and diagnose pre-malignant lesions and early cancers, and investigate different novel therapies. Many advances have been made in the study of esophageal and gastric cancers in the past decade. A scientific update is timely and these are the key areas that will be focused on in this proposed ASI. This workshop offers in-depth seminars on molecular, genetics and clinical studies on esophageal and gastric cancers. Five themes will be covered by the ASI: (1) Mechanisms of esophageal and gastric carcinogenesis; (2) Molecular genetic basis of esophageal and gastric cancers; (3) Stem cell and tumor microenvironment in esophageal and gastric cancers; (4) Prevention and diagnosis of early esophageal and gastric cancers; (5) Established and novel treatments of esophageal and gastric cancers.